A. Olsen

Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries

G. Fulcher, A. Kok, N. Nicodemus, 2022, Advances in Therapy.

Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries

G. Fulcher, A. Kok, N. Nicodemus, 2022, Advances in Therapy.

Long-term Effectiveness and Safety of GH Replacement Therapy in Adults ≥60 Years: Data From NordiNet® IOS and ANSWER

B. Biller, C. Höybye, Jean-Marc Ferran, 2023, Journal of the Endocrine Society.

Reduced CV risk with long-term GH replacement in AGHD: data from two large observational studies

B. Biller, C. Höybye, Jean-Marc Ferran, 2022, Endocrine connections.

Investigating the potential non‐authorized use of two different formulations of liraglutide in Europe: A real‐world drug utilization study

P. Sbraccia, A. Major-Pedersen, N. Rathor, 2022, Diabetes, obesity and metabolism.